The invention provides compounds having activity as bacterial RNA polymerase inhibitors and antibacterial agents, as well as compositions comprising the compounds and methods for their use. Specifically, phenylalanineamide and tyrosinamide compounds are disclosed that have inhibitory activity toward
mycobacterium
tuberculosis RNA polymerase. Use of these compounds in the treatment or prevention of
M. tuberculosis
infections in a mammal, is disclosed.